Status:
COMPLETED
Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes
Lead Sponsor:
Florida State University
Collaborating Sponsors:
Egg Nutrition Center
Conditions:
Diabetes Mellitus, Type 2
Obesity
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
The intent of this study is to examine the extent to which daily incorporation of egg into a diet improves glycemic control, insulin sensitivity, lipid profiles, and body composition in overweight and...
Detailed Description
Pre-diabetes is a condition that is characterized by elevated fasting blood glucose levels secondary to insulin resistance; however, fasting blood glucose levels are not elevated to the extent where i...
Eligibility Criteria
Inclusion
- Overweight and obese, BMI is between 25 kg/m2 and 45 kg/m2
- With pre- and type II-diabetes. Subjects will be eligible if their Hgb A1c level is \>5.6%
Exclusion
- Subjects with BMI≤ 24 or ≥46 kg/m2
- Uncontrolled hypertension (≥160/100 mmHg), active cancer, asthma, thyroid, glaucoma, kidney, liver and pancreatic diseases will be excluded from the study.
- Subjects who are participating in any weight loss program and/or are heavy smokers (more than 20 cigarettes per day) will be excluded from the study.
- Subjects who are allergic to egg and egg products will also be excluded from the study.
Key Trial Info
Start Date :
September 11 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2017
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT03272074
Start Date
September 11 2015
End Date
August 5 2017
Last Update
September 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida State University
Tallahassee, Florida, United States, 32306